0001213900-22-036868.txt : 20220701
0001213900-22-036868.hdr.sgml : 20220701
20220701191309
ACCESSION NUMBER: 0001213900-22-036868
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220701
FILED AS OF DATE: 20220701
DATE AS OF CHANGE: 20220701
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SETH SANDESH
CENTRAL INDEX KEY: 0001566175
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36374
FILM NUMBER: 221062777
MAIL ADDRESS:
STREET 1: 300 E 93RD STREET, #20-B
CITY: NEW YORK
STATE: NY
ZIP: 10128
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Actinium Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001388320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 880378336
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 275 MADISON AVENUE, 7TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10016
BUSINESS PHONE: 646-677-3875
MAIL ADDRESS:
STREET 1: 275 MADISON AVENUE, 7TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10016
FORMER COMPANY:
FORMER CONFORMED NAME: Cactus Ventures, Inc.
DATE OF NAME CHANGE: 20070130
4
1
ownership.xml
X0306
4
2022-07-01
0
0001388320
Actinium Pharmaceuticals, Inc.
ATNM
0001566175
SETH SANDESH
C/O ACTINIUM PHARMACEUTICALS,
INC., 275 MADISON AVENUE, 7TH FLOOR
NEW YORK,
NY
10016
1
1
0
0
Chief Executive Officer
Stock Option (Right to Buy)
4.96
2022-07-01
4
A
0
827366
0
A
2032-07-01
Common Stock
827366
827366
D
This price represents the closing price of the Company's common stock on July 1, 2022, the date of the grant.
Pursuant to the terms of the Company's 2019 Stock Plan, 2% of the options will vest each month from July 1, 2022 until fully vested.
/s/ Sandesh Seth
2022-07-01